Cargando…
Can an amino acid mixture alleviate gastrointestinal symptoms in neuroendocrine tumor patients?
BACKGROUND: Neuroendocrine tumors, although relatively rare in incidence, are now the second most prevalent gastrointestinal neoplasm owing to indolent disease biology. A small but significant sub-group of neuroendocrine tumor patients suffer from diarrhea. This is usually secondary to carcinoid syn...
Autores principales: | Chauhan, Aman, Das, Satya, Miller, Rachel, Luque, Laura, Cheuvront, Samuel N., Cloud, James, Tarter, Zach, Siddiqui, Fariha, Ramirez, Robert A., Anthony, Lowell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139143/ https://www.ncbi.nlm.nih.gov/pubmed/34016080 http://dx.doi.org/10.1186/s12885-021-08315-4 |
Ejemplares similares
-
Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients
por: Chauhan, Aman, et al.
Publicado: (2020) -
Management of Large Cell Neuroendocrine Carcinoma
por: Corbett, Virginia, et al.
Publicado: (2021) -
Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status
por: Chauhan, Aman, et al.
Publicado: (2018) -
Gynecologic large cell neuroendocrine carcinoma: A review
por: Burkeen, Grant, et al.
Publicado: (2020) -
Immune checkpoint inhibitors in neuroendocrine tumors: A single institution experience with review of literature
por: Chauhan, Aman, et al.
Publicado: (2017)